Before you continue
By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

1. Can Ozempic be used safely as a weight loss drug, and what are the risks involved?

Ozempic (semaglutide) is a prescription drug for management of type 2 diabetes, but it has also been studied for its weight loss effects. Off-label use without proper medical consultation may lead to gastrointestinal symptoms like nausea, vomiting, and diarrhea. Furthermore, there are a few rare but serious risks associated with off label use and include pancreatitis, gallbladder problems, and kidney problems. The only safe way to use Ozempic as a weight loss drug is to consult a doctor who will assess the different comorbidities that need to be considered.

2. How is the Ozempic shortage affecting patients who rely on the drug for medical reasons?

Abrupt stopping of the medication may have serious health implications for someone who is using it to manage a health condition. It could cause the glucose in the body to spike, potentially risking the lives of those with uncontrolled diabetes. Some reports suggest that people even ration their doses or discontinue the medication without any medical supervision. It is crucial for patients to communicate their requirements with their Doctor and then make any changes to their regimen to avoid serious medical consequences.  

4. What steps are being taken by healthcare providers and regulators to address the Ozempic shortage?

Novo Nordisk, manufacturer of Ozempic, is ramping up the development of the drug. As per a statement by the company, their 0.25 and 0.5 pens had the most supply disruptions, “due to the combination of tremendous demand coupled with overall global supply limitations”.

Consequently, various healthcare providers and pharmaceutical companies are looking to collaborate to seek the most effective solution to address the shortage. The healthcare world may witness new partnerships, increased production, and recommendations for alternative medications.

5. Are there alternative medications available for patients who are unable to access Ozempic?

Ozempic belongs to a category of medications called glucagon-like peptide-1 receptor agonists (GLP1 RAs) and all medication falling under the category can be considered as alternatives.

However, it is important to note that these medications affect different people differently depending on their medical histories. Healthcare providers assess individual needs and medical histories before prescribing the best alternative.  

6. How has social media played a role in the increased popularity of Ozempic as a weight loss drug?

The rise of social media influencers, celebrity endorsements, and internet marketing has contributed to the increased popularity of Ozempic. Social media provides a space for all individuals to present reviews as user testimonials, and is now a hub for reviews, hence providing credibility and accessibility to all individuals. There is a category of influencers who specialize in healthcare content, and they promote Ozempic as a weight loss drug without disclosing any potential health harm. This creates a lack of transparency between creators and users and highlights the importance of content regulations to ensure people receive accurate information.

7. How can healthcare providers ensure that their patients are receiving appropriate medical advice and treatment for their conditions?

It is crucial for health providers to encourage patients to not rely on health-related information from social media or internet. This will also encourage a healthy and transparent Doctor-patient relationship. Building their trust, listening to them, involving them in their care journey etc., can go a long way in ensuring the patient always discusses their health requirements with the doctor.

8. What lessons can be learned from the Ozempic shortage and its impact on patient care?

The harmful effects of social media are many, including effects on one’s mental health, which can lead to dire consequences. Patient care is not reliant on social media and other unreliable sources, but on credible doctors and hospitals. As far as pharmaceutical companies are concerned, they need to learn to diversify their supply chain and avoid dependency on one singular supplier that increases the vulnerability of shortage in the healthcare system. Patient education is also an essential factor when choosing alternative medication and creating a contingency plan.  

Dr. Ahmed Abdul Karim Hassoun


Myths & Facts about Diabetes

Myths & Facts about Diabetes

Fasting with Diabetes

Fasting with Diabetes